[1]
Zoah Syed et al. 2023. COMPARING DEFERASIROX AND DESFERRIOXAMINE AS IRON CHELATORS IN PATIENTS WITH BETA-THALASSEMIA MAJOR. Journal of Population Therapeutics and Clinical Pharmacology. 30, 17 (Sep. 2023), 1937–1942. DOI:https://doi.org/10.53555/jptcp.v30i17.2880.